ResMed Inc.
Market Cap
$34.08B
P/E Ratio
23.12
EPS
$10.10
Dividend Yield
0.92%
52-Week Range
$199.92 — $293.81
Volume
648.67K
Avg Volume
1.07M
Beta
0.89
P/E (TTM)
23.12
Forward P/E
21.12
PEG Ratio
7.19
P/S (TTM)
6.84
P/B (TTM)
5.86
P/FCF
113.37
EV/EBITDA
62.15x
EV/Sales
—
ROE (TTM)
0.25%
ROA (TTM)
0.17%
ROIC
0.07%
Gross Margin
0.61%
Operating Margin
0.34%
Net Margin
0.28%
Debt/Equity
0.16
Current Ratio
3.06
EPS Growth (YoY)
+0.14%
Revenue Growth (YoY)
+0.11%
EPS Growth (3Y)
+0.22%
EPS Growth (5Y)
+0.21%
Sales Growth (3Y)
+0.13%
Sales Growth (5Y)
+0.12%
EPS Est (This Year)
$11.06
EPS Est (Next Year)
$12.27
Dividend Yield
—
Annual Dividend
$0.60
Payout Ratio
0.22%
Frequency
—
Ex-Dividend Date
2025-11-13
Cash/Share
$9.74
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $295.88(26.7% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
145.97M
Float
144.78M
Free Float %
99.18%
RSI (14)
58.21
SMA 20
$259.23
SMA 50
$252.84
SMA 200
$262.05
ATR (14)
7.64
Volatility (Week)
0.03%
Volatility (Month)
0.02%
Pattern
—
1 Day
-4.50%
1 Week
+4.82%
1 Month
+4.38%
3 Months
+4.79%
6 Months
-7.31%
1 Year
—
YTD
+7.65%
All-Time High
$293.81
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
NYSE
IPO Date
1995-06-02
Employees
9980
CEO
Michael J. Farrell
Index Membership
S&P 500
Website
https://www.resmed.com
ResMed Inc. (RMD) is a healthcare company in the medical - instruments & supplies industry listed on the NYSE. With a market capitalization of $34.08B, a P/E ratio of 23.12, and a dividend yield of 0.92%, RMD is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare RMD against other stocks using dozens of fundamental and technical filters.
ResMed Inc. (RMD) has a trailing twelve-month (TTM) P/E ratio of 23.12. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, ResMed Inc. (RMD) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
ResMed Inc. (RMD) has a market capitalization of $34.08 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on ResMed Inc. (RMD) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $295.88 implies 26.7% upside from the current price.
ResMed Inc. (RMD) has returned +7.65% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.